Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells
American Journal of Physiology-Cell Physiology · 2023
DOI: 10.1152/ajpcell.00286.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2023. Verfasst von Xiaoqian Shan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. Hauptthemen laut MEDLINE: Calcium Signaling, Hypertension, Pulmonary, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: IMMU General Program, IMMU Graduate Education Teaching Reform Research Practice Project, IMMU Doctoral Starting Up Foundation.
Abstract (Originalsprache)
Aloperine attenuates monocrotaline-induced pulmonary hypertension (MCT-PH) in rats by inhibiting the pulmonary vascular remodeling and proliferation of pulmonary arterial smooth muscle cells (PASMCs). In mechanism, Aloperine not only exerts a transient KCNQ-dependent vasodilation in precontracted pulmonary arteries (PAs) from both control and MCT-PH rats but also activates PPARγ nuclear translocation and signaling transduction in PASMCs, which chronically inhibits the calcium regulatory pathway and proliferation of PASMCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospi…
- Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Inner Mongolia Minzu University, Tongliao, China.
- Department of Scientific Research, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Guangzhou National Laboratory, Guangzhou International Bio Island, Guangzhou, China.
- Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
ORCID-Profile: Xiaoqian Shan, Kai Yang
Förderung
- IMMU General Program
- IMMU Graduate Education Teaching Reform Research Practice Project
- IMMU Doctoral Starting Up Foundation
- 内蒙古自治区科学技术厅 | Natural Science Foundation of Inner Mongolia Autonomous Region
- MOST | National Natural Science Foundation of China
Zitieren
APA
Shan, X., Gegentuya, Wang, J., Feng, H., Zhang, Z., Zheng, Q., Zhang, Q., Yang, K., Wang, J., & Xu, L. (2023). Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00286.2023
Vancouver
Shan X, Gegentuya, Wang J, Feng H, Zhang Z, Zheng Q, et al. Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells. American Journal of Physiology-Cell Physiology. 2023. doi:10.1152/ajpcell.00286.2023
BibTeX
@article{Shan2023,
author = {Shan, Xiaoqian and Gegentuya and Wang, Jing and Feng, Huazhuo and Zhang, Zizhou and Zheng, Qiuyu and Zhang, Qing and Yang, Kai and Wang, Jian and Xu, Lei},
title = {Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells},
journal = {American Journal of Physiology-Cell Physiology},
year = {2023},
doi = {10.1152/ajpcell.00286.2023}
}
EUVIMED